Abstract
Use of chemotherapy and radiotherapy in the adjuvant setting has improved survival for many patients with malignancy. Unfortunately multimodality treatment can come at a price, in particular therapy-related malignancies. This has importance in that patients must be made aware of this potential detriment from therapy and doctors must consider this diagnosis in those patients who are cancer survivors and presenting with health problems. We present a case report and brief overview of the literature regarding chemotherapy-induced acute myeloid leukaemia (AML) following therapy for early stage breast cancer.
| Original language | English |
|---|---|
| Pages (from-to) | 97-9 |
| Number of pages | 3 |
| Journal | The Ulster Medical Journal |
| Volume | 82 |
| Issue number | 2 |
| Publication status | Published - May 2013 |
Keywords
- Antineoplastic Combined Chemotherapy Protocols
- Breast Neoplasms
- Carcinoma, Ductal, Breast
- Chemoradiotherapy, Adjuvant
- Cyclophosphamide
- Doxorubicin
- Fatal Outcome
- Female
- Humans
- Leukemia, Myeloid, Acute
- Mastectomy
- Middle Aged
- Tamoxifen
- Case Reports
- Journal Article
- Review
